AL Amyloidosis

Rob DillardCardiology | July 9, 2021
Apixaban Reduces the Risk of Hemorrhage in VTE Patients ...
Read More
Jessie Holtzman, MDCardioNerds | July 8, 2021
This article was written by Jesse Holzman, MD, and internal medicine resident at the University of California and a ...
Rebecca AraujoASH Annual Meeting 2020 | July 5, 2023
Findings presented at the 2020 American Society of Hematology Annual Meeting & Exposition suggest that ejection ...
Rebecca AraujoASH Annual Meeting 2020 | April 19, 2023
A regimen of ixazomib, cyclophosphamide, and dexamethasone produced hematologic responses in 57% of patients with ...
Rebecca AraujoASH Annual Meeting 2020 | April 19, 2023
Individuals with light-chain (AL) amyloidosis have higher odds of severe SARS-CoV-2 infection or mortality compared with ...
Rebecca AraujoASH Annual Meeting 2020 | April 19, 2023
Therapy with isatuximab for previously treated light-chain (AL) amyloidosis was found to be effective and safe, ...
Rebecca AraujoOncology | July 5, 2023
Maintenance therapy following autologous hematopoietic cell transplantation (AHCT) did not significantly impact survival ...
Rebecca AraujoOncology | March 31, 2023
Researchers from the Washington University School of Medicine developed a prediction model that may improve timely ...
Rebecca AraujoOncology | April 23, 2023
The ratio of left ventricular (LV) mass to electrocardiographic (EKG) voltage was associated with subsequent heart ...
Rebecca AraujoOncology | July 5, 2023
In light-chain (AL) amyloidosis, a rare plasma cell disease marked by excess deposit of protein in the organs, the goal ...
Rebecca AraujoCOVID-19 | April 6, 2023
Light-chain (AL) amyloidosis is a rare immune system disorder marked by the buildup of malformed proteins, called ...
Rebecca AraujoOncology | March 31, 2023
Right heart evaluation may be considered a marker for clinical risk stratification in patients with cardiac amyloidosis ...
Rebecca AraujoOncology | March 31, 2023
Findings published in Clinical Research in Cardiology showed that non-invasive cardiovascular magnetic resonance (CMR) ...
Rebecca AraujoOncology | July 5, 2023
Researchers from the Cedars-Sinai Medical Center found that cardiac transplantation can be safely performed in select ...
Rebecca AraujoOncology | March 31, 2023
A study published in the Journal of Nuclear Cardiology found that the 18F-flutemetamol positron emission tomography ...
Rebecca AraujoOncology | March 31, 2023
A study published in Blood Cancer Journal found that pleural effusion was strongly associated with poor right ...
Rebecca AraujoOncology | March 31, 2023
Racial and ethnic minorities comprise only a small percentage of patients seen at specialized treatment centers for ...
Rebecca AraujoOncology | March 31, 2023
A study from researchers at the University of Pavia in Italy, confirmed that current response criteria for an amyloid ...
Rebecca AraujoOncology | March 31, 2023
A new study from an Israeli research team observed favorable safety, tolerability, and efficacy of daratumumab for the ...
Advertisement
Advertisement
Latest News

April 19, 2024